Evaluating the Survival Rate and the Secondary Malignancies after Treating Hodgkin's Lymphoma Patients with Chemotherapy Regimens

In this study we surveyed the average survival time of the treated Hodgkin's lymphoma patients and also the side effects and malignancies occurring secondary to the treatment. This is a retrospective study of patients referring to Ahwaz's Shafa hospital in a period of 10 years diagnosed wi...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hematology- oncology and stem cell research 2014, Vol.8 (2), p.21-26
Main Authors: Ahmadzadeh, Ahmad, Yekaninejad, Mir Saeed, Jalili, Mohamad H, Bahadoram, Mohammad, Efazat, Mehdi, Seghatoleslami, Mohammad, Yazdi, Fatemeh, Mahdipour, Mozhdeh, Valizadeh, Armita, Saki, Najmaldin
Format: Article
Language:English
Subjects:
Chemotherapy
Hodgkin
Original
Second malignancy
Survival
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this study we surveyed the average survival time of the treated Hodgkin's lymphoma patients and also the side effects and malignancies occurring secondary to the treatment. This is a retrospective study of patients referring to Ahwaz's Shafa hospital in a period of 10 years diagnosed with Hodgkin's lymphoma without any age restriction. After gathering all their data, we calculated their survival rate and the chance for a relapse and the secondary malignancies. 389 patients were included in the study with an average age of 27.5 years old and they had received only chemotherapy regimens. 87.9% of them had been treated by ABVD and 12.1 % by Stanford V regimen. 23.1% of them experienced a relapse and 13.1% of all patients, passed away during the study. Secondary malignancies were observed in 11 cases. An overall mean survival time of 295.31 months was resulted. The secondary malignancies after treating Hodgkin's lymphoma patients are different between chemotherapy regimens and chemotherapy – radiotherapy.
ISSN:2008-3009
2008-2207